In yesterday’s Wall Street session, Ventas Inc. (NYSE:VTR) shares traded at $44.93, down -6.82% from the previous session.
19 analysts cover Ventas Inc. (NYSE:VTR), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $80.00 and a low of $45.00, we find $53.00. Given the previous closing price of $48.22, this indicates a potential upside of 9.91 percent. VTR stock price is now -3.77% away from the 50-day moving average and -2.22% away from the 200-day moving average. The market capitalization of the company currently stands at $19.29B.
The stock has received a hold rating from 7 analysts and a buy rating from 10. Brokers who have rated the stock have averaged $53.94 as their price target over the next twelve months.
With the price target maintained at $55, Raymond James recently Upgraded its rating from Outperform to Strong Buy for Ventas Inc. (NYSE: VTR).
In other news, RAKOWICH WALTER C, Director sold 1,242 shares of the company’s stock on May 26. The stock was sold for $52,870 at an average price of $42.57. Upon completion of the transaction, the Director now directly owns 24,528 shares in the company, valued at $1.1 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 02, Chairman and CEO CAFARO DEBRA A sold 32,932 shares of the business’s stock. A total of $1,736,834 was realized by selling the stock at an average price of $52.74. This leaves the insider owning 863,555 shares of the company worth $38.8 million. Insiders disposed of 223,094 shares of company stock worth roughly $10.02 million over the past 1 year. A total of 0.55% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in VTR stock. A new stake in Ventas Inc. shares was purchased by WALLEYE CAPITAL LLC during the first quarter worth $24,072,000. QUBE RESEARCH & TECHNOLOGIES LTD invested $11,956,000 in shares of VTR during the first quarter. In the first quarter, ADAMS DIVERSIFIED EQUITY FUND, INC. acquired a new stake in Ventas Inc. valued at approximately $9,256,000. LIGHTHOUSE INVESTMENT PARTNERS, LLC acquired a new stake in VTR for approximately $8,986,000. GRS ADVISORS, LLC purchased a new stake in VTR valued at around $7,745,000 in the second quarter. In total, there are 978 active investors with 95.10% ownership of the company’s stock.
During the past 12 months, Ventas Inc. has had a low of $35.33 and a high of $53.15. The fifty day moving average price for VTR is $46.70 and a two-hundred day moving average price translates $45.99 for the stock.
The latest earnings results from Ventas Inc. (NYSE: VTR) was released for Jun, 2023. According to the REIT – Healthcare Facilities Company, earnings per share came in at $0.04, beating analysts’ expectations of -$0.1 by 0.14. This compares to $0.10 EPS in the same period last year. The net profit margin was -1.10% and return on equity was -0.50% for VTR. The company reported revenue of $1.08 billion for the quarter, compared to $1.02 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 5.87 percent. For the current quarter, analysts expect VTR to generate $1.09B in revenue.
Moreover, the firm recently paid out its quarterly dividend on 07/13/2023. Investors who held shares on 07/03/2023 were paid a $0.45 dividend. On an annualized basis, this represents a $1.80 dividend and a 4.01% percent yield. There was an ex-dividend date of 06/30/2023 for this dividend.
Ventas Inc.(VTR) Company Profile
Ventas Inc., an S&P 500 company, operates at the intersection of two large and dynamic industries healthcare and real estate. Fueled by powerful demographic demand from growth in the aging population, Ventas owns or has investments in a highly diversified portfolio of approximately 1,400 properties in the United States, Canada, and the United Kingdom. Ventas uses the power of its capital to unlock the value of senior housing communities, outpatient medical buildings, research centers, hospitals and other healthcare facilities. A globally-recognized real estate investment trust, Ventas follows a successful long-term strategy, proven over more than 20 years, built on diversification of property types, capital sources and industry leading partners, financial strength and flexibility, consistent and reliable growth and industry leading ESG achievements, managed by a collaborative and experienced team dedicated to its stakeholders.
